N-glycosylation of ICAM-2 is required for ICAM-2-mediated complete suppression of metastatic potential of SK-N-AS neuroblastoma cells

BMC Cancer

Volumn 13, Issue , 2013, Pages

  Feduska, Joseph M ^a   Garcia, Patrick L ^a   Brennan, Stephanie B ^a   Bu, Su ^a   Council, Leona N ^b   Yoon, Karina J ^a  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

CD102; Cell motility; ICAM 2; Metastasis; N glycosylation; Neuroblastoma

Indexed keywords

ALANINE; ALPHA ACTININ; ASPARAGINE; F ACTIN; INTERCELLULAR ADHESION MOLECULE 2; ACTIN; CELL ADHESION MOLECULE; ICAM-2 PROTEIN, MOUSE; LEUKOCYTE ANTIGEN;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CANCER SURVIVAL; CELL BASED GENE THERAPY; CELL MOTILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG TARGETING; EXPERIMENTAL MOUSE; FEMALE; GENE FUNCTION; GENE LOCATION; GENETIC TRANSFECTION; GENETIC VARIABILITY; GLYCOSYLATION; HUMAN; HUMAN CELL; ICAM 2 GENE; IN VITRO STUDY; IN VIVO STUDY; METASTASIS INHIBITION; METASTASIS POTENTIAL; MOUSE; NEUROBLASTOMA; NONHUMAN; PHENOTYPE; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; SITE DIRECTED MUTAGENESIS; AMINO ACID SEQUENCE; ANIMAL; CELL MOTION; CELL PROLIFERATION; CHEMISTRY; DRUG SCREENING; FLOW CYTOMETRY; IMMUNOBLOTTING; IMMUNOPRECIPITATION; METABOLISM; MOLECULAR GENETICS; PATHOLOGY; TUMOR CELL LINE; TUMOR INVASION;

ACTINS; AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD; CELL ADHESION MOLECULES; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; FLOW CYTOMETRY; GLYCOSYLATION; HUMANS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MICE; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; NEOPLASM INVASIVENESS; NEUROBLASTOMA; TRANSFECTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84878227152     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-13-261     Document Type: Article

References (45)

1. Kawauchi T. Cell adhesion and its endocytic regulation in cell migration during neural development and cancer metastasis. Int J Mol Sci 2012, 13(4):4564-4590. 3344232, 22605996.
2. Dallas MR, Liu G, Chen WC, Thomas SN, Wirtz D, Huso DL, Konstantopoulos K. Divergent roles of CD44 and carcinoembryonic antigen in colon cancer metastasis. FASEB J 2012, 26(6):2648-2656. 10.1096/fj.12-203786, 3360151, 22415308.
3. Leda J, Yokoyama S, Tamura K, Takifuji K, Hotta T, Matsuda K, Oku Y, Nasu T, Kiriyama S, Yamamoto N, Nakamura Y, Shively JE, Yamaue H. Re-expression of CEACAM1 long cytoplasmic domain isoform is associated with invasion and migration of colorectal cancer. Int J Cancer 2011, 129(6):1351-1361. 10.1002/ijc.26072, 21413011.
4. Ngora H, Galli UM, Miyazaki K, Zoller M. Membrane-bound and exosomal metastasis-associated C4.4A promotes migration by associating with the α(6)β(4) integrin and MT1-MMP. Neoplasia 2012, 14(2):95-107. 3306255, 22431918.
5. Dalva MB, McClelland AC, Kayser MS. Cell adhesion molecules: signaling functions at the synapse. Nature Rev Neuroasience 2007, 8:206-220.
6. Williams AF, Barclay AN. The immunoglobulin superfamily-domains for cell surface recognition. Ann Rev Immunol 1988, 6:381-405.
7. Casasnovas JM, Springer TA, Liu J, Harrison SC, Wang J. Crystal structure of ICAM-2 reveals a distinctive integrin recognition surface. Nature 1997, 387(15):312-315.
8. Nortamo P, Salcedo R, Timonen T, Patarroyo M, Gahmberg CG. A monoclonal antibody to the human leukocyte adhesion molecule intercellular adhesion molecule-2. J Immunol 1991, 146:2530-2535.
9. de Fougerolles AR, Stacker SA, Schwarting R, Springer TA. Characterization of ICAM-2 and evidence for a third counter-receptor for LFA-1. J Exp Med 1991, 174:253-257. 10.1084/jem.174.1.253, 2118873, 1676048.
10. Kotovuori A, Pessa-Morikawa T, Kotovuori P, Nortamo P, Gahmberg CG. ICAM-2 and a peptide from its binding domain are efficient activators of leukocyte adhesion and integrin affinity. J Immunol 1999, 162(11):6613-6620.
11. Reiss Y, Engelhardt B. T cell interaction with ICAM-1-deficient endothelium in vitro: transendothelial migration of endothelial ICAM-1 and ICAM-2. Int Immunol 1999, 11(9):1527-1539. 10.1093/intimm/11.9.1527, 10464174.
12. Huang M-T, Larbi KY, Scheiermann C, Woodfin A, Gerwin N, et al. ICAM-2 mediates neutrophils transmigration in vivo: evidence for stimulus specificity and a role in PECAM-2-independent transmigration. Blood 2006, 107:4721-4727. 10.1182/blood-2005-11-4683, 16469869.
13. Yoon KJ, Phelps DA, Bush RA, Remack JS, Billups CA, Khoury JD. ICAM-2 expression mediates a membrane-actin link, confers a nonmetastatic phenotype and reflects favorable tumor stage or histology in neuroblastoma. PLoS One 2008, 3(11):e3629. 10.1371/journal.pone.0003629, 2575377, 18978946.
14. Huang MT, Mason JC, Birdsey GM, Amsellem V, Gerwin N, Haskard DO, Ridley AJ, Randi AM. Endothelial intercellular adhesion molecule (ICAM)-2 regulates angiogenesis. Blood 2005, 106(5):1636-1643. 10.1182/blood-2004-12-4716, 15920013.
15. Yonemura S, Hirao M, Doi Y, Takahashi N, Kondo T, et al. Ezrin/radixin/moesin (ERM) proteins bind to a positively charged amino acid cluster in the juxta-membrane cytoplasmic domain of CD44, CD43, and ICAM-2. J Cell Biol 1998, 40:885-895.
16. Heiska L, Kantor C, Parr T, Critchley DR, Vilja P, et al. Binding of the cytoplasmic domain of intercellular adhesion molecule-2 (ICAM-2) to a-actinin. J Biol Chem 1999, 271:26214-26219.
17. Jimenez D, Roda-Navarro P, Springer TA, Casasnovas JM. Contribution of N-linked glycans to the conformation and function of intercellular adhesion molecules (ICAMs). J Biol Chem 2005, 280(7):5854-5861.
18. Jamal BT, Nita-Lazar M, Gao Z, Amin B, Walker J, Kukuruzinska MA. N-glycosylation status of E-cadherin controls cytoskeletal dynamics through the organization of distinct β-catenin-and γ-catenin-containing AJs. Cell Health Cytoskelet 2009, 1:67-80.
19. Zhao H, Liang Y, Xu Z, Wang L, Zhou F, Li Z, Jin J, Yang Y, Fang Z, Hu Y, Zhang L, Su J, Zha X. N-glycosylation affects the adhesive function of E-cadherin through modifying the composition of adherens junctions (AJs) in human breast carcinoma cell line MDA-MB-435. J Cell Biochem 2008, 104:162-175. 10.1002/jcb.21608, 17979184.
20. Horst AK, Bickert T, Brewig N, van Rooijen N, Schumacher U, Beauchemin N, Ito WD, Fleischer B, Wagner C, Ritter U. CEACAM1+ myeloid cells control angiogenesis in inflammation. Blood 2009, 113(26):6726-6736. 10.1182/blood-2008-10-184556, 19273835.
21. Guo H-B, Lee I, Kamar M, Akiyama SK, Pierce M. Aberrant N-glycosylation of b1 integrin causes reduced a5b1 integrin clustering and stimulate cell migration. Cancer Res 2002, 62:6837-6845.
22. Nita-Lazar M, Noonan V, Rebustini I, Walker J, Menko AS, Kukuruzinska MA. Overexpression of DPAGT1 leads to aberrant N-glycosylation of E-cadherin and cellular discohesion in oral cancer. Cancer Res 2009, 69(14):5673-5680. 10.1158/0008-5472.CAN-08-4512, 2771190, 19549906.
23. Rood PM, Calafat J, von dem Borne AE, Gerritsen WR, van der Schoot CE. Immortalisation of human bone marrow endothelial cells: characterization of new cell lines. Eur J Clin Invest 2000, 30:618-629. 10.1046/j.1365-2362.2000.00672.x, 10886302.
24. Polanska UM, Duchesne L, Harries JC, Fernig DG, Kinnunen TK. N-glycosylation regulates fibroblast growth factor receptor/EGL-15 activity in Caenorhabditis elegans in vivo. J Biol Chem 2009, 284(48):33030-33039. 10.1074/jbc.M109.058925, 2785143, 19801543.
25. Skropeta D, Settasatian C, McMahon MR, Shearston K, Caiazza D, McGrath KC, Jin W, Rader DJ, Barter PJ, Rye KA. N-glycosylation regulates endothelial lipase-mediated phospholipid hydrolysis in apoE- and apoA-I-containing high density pipoproteins. J Lipid Res 2007, 48:2047-2057. 10.1194/jlr.M700248-JLR200, 17545692.
26. Morrison KL, Weiss GA. Combinational alanine-scanning. Curr Opin Chem Biol 2001, 5:302-307. 10.1016/S1367-5931(00)00206-4, 11479122.
27. Mohamet L, Lea ML, Ward CM. Abrogation of E-cadherin-mediated cellular aggregation allows proliferation of pluripotent mouse embryonic stem cells in shake flask bioreactors. PLoS One 2010, 5(9):e12921. 10.1371/journal.pone.0012921, 2944850, 20886069.
28. Hong X, Jiang F, Kalkanis SN, Zhang ZG, Zhang X, Zheng X, Jiang H, Mikkelsen T, Chopp M. Increased chemotactic migration and growth in heparanase-overexpressing human U251n glioma cells. J Exp Clin Cancer Res 2008, 27(1):23. 10.1186/1756-9966-27-23, 2499998, 18647407.
29. Liang CC, Park AY, Guan JL. In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc 2007, 2(2):329-333. 10.1038/nprot.2007.30, 17406593.
30. Moralli D, Monaco ZL. Simultaneous detection of FISH signals and bromo-depxyuridine incorporation in fixed tissue cultured cells. PLoS One 2009, 4(2):e4483. 10.1371/journal.pone.0004483, 2637417, 19221585.
31. Heineke J, Auger-Messier M, Correll RN, Xu J, Benard MJ, Yuan W, Drexler H, Parise LV, Molkentin JD. CIB1 is a regulator of pathological cardiac hypertrophy. Nat Med 2010, 16(8):872-879. 10.1038/nm.2181, 2917617, 20639889.
32. Morton CL, Lacono L, Hyatt JL, Taylor KR, Cheshire PJ, Houghton PJ, Danks MK, Stewart CF, Potter PM. Activation and antitumor activity of CPT-11 in plasma esterase-deficient mice. Cancer Chemother Pharmacol 2005, 56:629-636. 10.1007/s00280-005-1027-y, 15918039.
33. Wagner LM, Guichard SM, Burger RA, Morton CL, Straign CM, Ashmun RA, Harris LC, Houghton PJ, Potter PJ, Danks MK. Efficacy and toxicity of a virus-directed enzyme prodrug therapy purging method: preclinical assessment and application to bone marrow samples from neuroblastoma patients. Cancer Res 2002, 62:5001-5007.
34. Dickson PV, Hammer JB, Burger RA, Garcia E, Ouma AA, Kim SU, Ng CYC, Gray JT, Aboody KS, Danks MK, Davidoff AM. Intravascular administration of tumor tropic neural progenitor cells permits targeted delivery of interferon-β and restricts tumor growth in a murine model of disseminated neuroblastoma. J Ped Surgery 2007, 42:48-53.
35. Li R, Nortamo P, Valmu L, Tolvanen M, Huuskonen J, Kantor C, Gahmberg CG. A peptide from ICAM-2 binds to the leukocyte integrin CD11a/CD18 and inhibits endothelial cell adhesion. J Biol Chem 1993, 268:17513-17518.
36. Diacovo AG, de Fougerlles AR, Bainton DF, Springer TA. A functional integrin ligand on the surface of platelets: Intercellular adhesion molecule-2. J Clin Invest 1994, 94:1243-1251. 10.1172/JCI117442, 295209, 8083366.
37. Casasnovas JM, Piersono C, Springer TA. Lymphatic function-associated antigen-1 binding residues in intercellular adhesion molecule-2 (ICAM-2) and the integrin binding surface in the ICAM family. Proc Natl Acad Sci USA 1999, 96:3017-3022. 10.1073/pnas.96.6.3017, 15887, 10077629.
38. Bocci G, Nicolaou KC, Kerbel RS. Protracted low-dose effects on human endothelial cell proliferation and survival in vitro reveal a selective antiangiogenic window for various chemotherapeutic drugs. Cancer Res 2002, 62(23):6938-6943.
39. Ridley AJ, Schwartz MA, Burridge K, Firtel RA, Ginsberg MH, Borisy G, Parsons JT, Horwitz AR. Cell migration: Integrating signals from front to back. Science 2003, 302:1704-1709. 10.1126/science.1092053, 14657486.
40. Friedl P, Wolf K. Plasticity of cell migration: a multiscale tuning model. J Cell Biol 2009, 188(1):11-19. 2812848, 19951899.
41. Stevenson RP, Veltman D, Machesky LM. Actin-bundling proteins in cancer progression at a glance. J Cell Sci 2012, 125(5):1073-1079. 10.1242/jcs.093799, 22492983.
42. Mori S, Chang JT, Andrechek ER, Matsumura N, Baba T, Yao G, Kim JW, Gatza M, Murphy S, Nevin JR. Anchorage-independent cell growth identifies tumors with metastatic potential. Oncogene 2009, 28(31):2796-2805. 10.1038/onc.2009.139, 3008357, 19483725.
43. Takahashi M, Furihata M, Akimitsu N, Watanabe M, Kaul S, Yumoto N, Okada T. A highly bone marrow metastatic murine breast cancer model established through in vivo selection exhibits enhanced anchorage-independent growth and cell migration mediated by ICAM-1. Clin Exp Metastasis 2008, 25(5):517-529. 10.1007/s10585-008-9163-5, 18340424.
44. Cifone MA, Fidler IJ. Correlation patterns of anchorage-independent growth with in vivo behavior of cells from a murine fibrosarcoma. Proc Natl Acad Sci U S A 1980, 77(2):1039-1043. 10.1073/pnas.77.2.1039, 348419, 6928659.
45. Kuhlman PA, Ellis J, Critchley DR, Bagshaw CR. The kinetics of the interaction between the actin-binding domain of alpha-actinin and F-actin. FEBS Lett 1994, 339:297-301. 10.1016/0014-5793(94)80434-6, 8112470.